Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2020
Dec. 31, 2019
CURRENT ASSETS:    
Cash and cash equivalents $ 20,561,982 $ 13,928,504
Restricted cash 479,128 679,006
Investments 11,299,604 9,449,650
Trade accounts receivable, less allowance for doubtful accounts of $151,000 and $154,000, respectively 6,565,654 10,242,405
Inventories 8,089,911 8,531,112
Prepaid income taxes 77,078 72,994
Other current assets 1,118,883 1,160,865
Current assets held for sale   5,337,274
TOTAL CURRENT ASSETS 48,192,240 49,401,810
PROPERTY, PLANT AND EQUIPMENT, net 7,951,593 8,238,089
OTHER ASSETS:    
Investments 355,000 250,000
Deferred income taxes   9,534
Operating lease right of use asset 339,933 367,909
Noncurrent assets held for sale   883,370
TOTAL OTHER ASSETS 694,933 1,510,813
TOTAL ASSETS 56,838,766 59,150,712
CURRENT LIABILITIES:    
Accounts payable 2,675,534 3,720,445
Accrued compensation and benefits 2,390,525 3,517,331
Operating lease liability 113,022 115,935
Other accrued liabilities 2,220,269 2,602,752
Dividends payable 200,708 200,363
Current liabilities held for sale   1,193,218
TOTAL CURRENT LIABILITIES 7,600,058 11,350,044
LONG TERM LIABILITIES:    
Long-term compensation plans 67,175 164,348
Operating lease liability 208,831 244,038
TOTAL LONG-TERM LIABILITIES 276,006 408,386
COMMITMENTS AND CONTINGENCIES (Footnote 8)
STOCKHOLDERS' EQUITY    
Preferred stock, par value $1.00 per share; 3,000,000 shares authorized; none issued
Common stock, par value $.05 per share; 30,000,000 shares authorized; 9,346,966 and 9,252,749 shares issued and outstanding, respectively 467,347 462,637
Additional paid-in capital 43,381,778 42,977,914
Retained earnings 5,957,796 4,649,395
Accumulated other comprehensive loss (844,219) (697,664)
TOTAL STOCKHOLDERS' EQUITY 48,962,702 47,392,282
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 56,838,766 $ 59,150,712